Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062757) titled 'Morphological and Biochemical Characterization of Novel Peptides Produced in Human Pancreatic Islets' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Hyogo Medical University
Condition:
Condition - Patients with pancreatic or biliary diseases undergoing pancreatectomy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Identification of the Producing Cells, Molecular Forms, and Biological Functions of Novel Peptides in Human Pancreatic Islets
Basic objectives2 - Bio-availability
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients with pancreatic or bile duct diseases undergoing pancreatectomy
Key exclusion criteria - Patients receiving systemic corticosteroid therapy
Patients with diabetes mellitus
Patients who have received preoperative chemotherapy
Patients with active hepatitis
Patients with dyspnea requiring supplemental oxygen due to interstitial pneumonia, pulmonary fibrosis, or other respiratory disorders
Patients undergoing dialysis for chronic renal failure
Patients with inflammatory bowel disease
Patients with an active infection, excluding cholangitis
Patients with psychiatric disorders or psychiatric symptoms that are considered to make participation in the study difficult
Patients deemed unsuitable for participation in the study by the principal investigator for any other reason
Target Size - 10
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 14 Day
Anticipated trial start date - 2026 Year 09 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071219
Disclaimer: Curated by HT Syndication.
